These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9728252)

  • 1. Damage to tumour and brain by interstitial photodynamic therapy in the 9L rat tumour model comparing intravenous and intratumoral administration of the photosensitiser.
    Hebeda KM; Kamphorst W; Sterenborg HJ; Wolbers JG
    Acta Neurochir (Wien); 1998; 140(5):495-501. PubMed ID: 9728252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence localization in tumour and normal brain after intratumoral injection of haematoporphyrin derivative into rat brain tumour.
    Hebeda KM; Wolbers JG; Sterenborg HJ; Kamphorst W; van Gemert MJ; van Alphen HA
    J Photochem Photobiol B; 1995 Jan; 27(1):85-92. PubMed ID: 7699526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of 9L gliosarcomas to photodynamic therapy.
    Chopp M; Dereski MO; Madigan L; Jiang F; Logie B
    Radiat Res; 1996 Oct; 146(4):461-5. PubMed ID: 8927718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM; Wang KK; Zinsmeister AR
    Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
    Wang Y; Lin Y; Zhang HG; Zhu J
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain.
    Hebeda KM; Saarnak AE; Olivo M; Sterenborg HJ; Wolbers JG
    Acta Neurochir (Wien); 1998; 140(5):503-12; discussion 512-3. PubMed ID: 9728253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy of brain tumours.
    Kaye AH; Hill JS
    Ann Acad Med Singap; 1993 May; 22(3 Suppl):470-81. PubMed ID: 8215203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematoporphyrin derivative photoradiation therapy of the rat 9L gliosarcoma brain tumor model.
    Boggan JE; Edwards MS; Berns MW; Walter RJ; Bolger CA
    Lasers Surg Med; 1984; 4(1):99-105. PubMed ID: 6235423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.
    Jiang F; Lilge L; Belcuig M; Singh G; Grenier J; Li Y; Chopp M
    Lasers Surg Med; 1998; 23(3):161-6. PubMed ID: 9779650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin.
    Jiang F; Lilge L; Logie B; Li Y; Chopp M
    Photochem Photobiol; 1997 Apr; 65(4):701-6. PubMed ID: 9114747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
    Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
    Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue.
    Dellian M; Abels C; Kuhnle GE; Goetz AE
    Br J Cancer; 1995 Nov; 72(5):1125-30. PubMed ID: 7577457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification by vasoactive drugs of tumour destruction by photodynamic therapy with haematoporphyrin derivative.
    Cowled PA; Forbes IJ
    Br J Cancer; 1989 Jun; 59(6):904-9. PubMed ID: 2525402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of hematoporphyrin derivative in the rat 9l gliosarcoma brain tumor analyzed by digital video fluorescence microscopy.
    Boggan JE; Walter R; Edwards MS; Borcich JK; Davis RL; Koonce M; Berns MW
    J Neurosurg; 1984 Dec; 61(6):1113-9. PubMed ID: 6239014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.
    Lilge L; Olivo MC; Schatz SW; MaGuire JA; Patterson MS; Wilson BC
    Br J Cancer; 1996 Feb; 73(3):332-43. PubMed ID: 8562339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of photosensitizers in combination with laser and ACNU on an in vivo or in vitro model of cerebral glioma.
    Chen KT; Hau DM; You JS; Pan HC; Wong RW
    Chin Med J (Engl); 1995 Feb; 108(2):98-104. PubMed ID: 7774398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoradiation therapy of 9L-gliosarcoma in rats: hematoporphyrin derivative (types I and II) followed by laser energy.
    Cheng MK; McKean J; Mielke B; Tulip J; Boisvert D
    J Neurooncol; 1985; 3(3):217-28. PubMed ID: 4056851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy of malignant brain tumors].
    Kostron H; Grunert V
    Wien Klin Wochenschr; 1987 May; 99(11):389-92. PubMed ID: 2956770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Photodynamic therapy of hematoporphyrin derivative on human pancreatic carcinoma cell lines].
    Zhao Y; Yang B; Zhang T; Cai L; Zhu Y
    Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):204-7. PubMed ID: 11832030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
    Winther JB
    Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.